Form 4: ClearPoint Neuro Director Acquires Shares in Lieu of Fees

Director R. John Fletcher acquired 1,072 shares of ClearPoint Neuro, Inc. common stock on July 1, 2024, in lieu of fees owed under the company's Non-Employee Director Compensation Plan.

Summary

• On July 1, 2024, R. John Fletcher, a director of ClearPoint Neuro, Inc., acquired 1,072 shares of common stock.
• The shares were issued as payment for fees owed to Fletcher under the company's Non-Employee Director Compensation Plan.
• The shares were issued at a price of $5.39 per share, based on the closing price of ClearPoint Neuro's common stock on June 28, 2024.
• Following the transaction, Fletcher beneficially owns 93,022 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director taking shares instead of cash is a slightly positive sign.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• Using shares to pay director fees conserves cash for the company.

Industry Context

Directors receiving stock in lieu of cash compensation is a common practice, especially for smaller companies, to preserve cash and align director interests with shareholders.

Stakeholder Impact

• Shareholders may view the director accepting stock in lieu of cash as a positive sign, indicating confidence in the company's future prospects.
• The company benefits from conserving cash by issuing stock instead of cash payments for director fees.

Key Dates